PEDIATRICS Vol. 105 No. 1 January 2000, pp. 73-78
Received Dec 31, 1999; accepted Jul 6, 1999.
,
From the * Unit for Pediatric Oncology and Hematology,
Department of Women's and Children's Health, Uppsala University
Children's Hospital, Uppsala, Sweden;
Department of Pediatric
Anesthesia and Intensive Care, Sahlgrenska University Hospital,
Sahlgrenska, Sweden; § Multidisciplinary Center for Pain Treatment,
Department of Anesthesiology and Intensive Care, University Hospital,
Uppsala, Sweden; and the
Department of Research, Central Hospital,
Västerås, Sweden.
Objective. Anxiety and pain even in minor procedures are still great problems in pediatrics, not least in pediatric oncology. Conscious sedation is indicated when other means to overcome a child's fear fail. The aim of this study was to investigate whether intranasal administration of midazolam given before insertion of a needle in a subcutaneously implanted central venous port could reduce anxiety, discomfort, pain, and procedure problems.
Method. Forty-three children with cancer participated in this randomized, double-blind, placebo-controlled, crossover study in which nasal administration of midazolam spray, .2 mg/kg body weight, was compared with placebo. Children, parents, and nurses completed a visual analog scale questionnaire to evaluate efficacy.
Results. Parents and nurses reported reduced anxiety,
discomfort, and procedure problems for children in the midazolam group
and would prefer the same medication at next procedure. They
also reported pain reduction. Children reported reduced anxiety and
procedure problems but reduction of pain and discomfort was not
significant. No serious or unexpected side effects occurred. Nasal
discomfort was the most common side effect (17/38
45%) and
the primary reason for dropouts (8/43
19%).Anxiety varied with age but not with gender. When anxiety increased,
the differences between midazolam and placebo increased.
Conclusion. Nasal midazolam spray offers relief to children anxious about procedures, such as insertion of a needle in a subcutaneously implanted intravenous port, venous blood sampling, venous cannulation, etc. Its use, however, may be limited by nasal discomfort in some patients for whom rectal and oral routes might be alternatives. Key words: pediatric procedure sedation, anxiety, procedure, midazolam, administration, intranasal.
This article has been cited by other articles:
![]() |
J. Laham Propofol: Risk vs. Benefit Clinical Pediatrics, January 1, 2002; 41(1): 5 - 7. [PDF] |
||||
![]() |
M. E. McCann and Z. N. Kain The Management of Preoperative Anxiety in Children: An Update Anesth. Analg., July 1, 2001; 93(1): 98 - 105. [Full Text] [PDF] |
||||
![]() |
R D W Hain, C Campbell, S SPACE, S KHARASCH, and H BAUCHNER Invasive procedures carried out in conscious children: contrast between North American and European paediatric oncology centres Arch. Dis. Child., July 1, 2001; 85(1): 12 - 15. [Abstract] [Full Text] [PDF] |
||||